The Department of Health - Abu Dhabi (DoH), the regulator of the healthcare sector in the emirate, has announced the ...

The innovative treatment, provided by Abu Dhabi Stem Cells Center (ADSCC), in coordination with DoH and in collaboration with ...

The renowned spiritual leader extends his support to the society's efforts in raising awareness and providing care for ...

CRISPR Therapeutics poised for growth with international potential and clinical assets. Read why I rate CRSP stock a Strong ...

In this interview, News Medical speaks with Olivier Negre, Chief Scientific Officer at Smart Immune, about how immunotherapy ...

Since the beginning of Ramadan, the number of blood donors has sharply decreased, leaving the banks struggling to meet the ...

Anemia remains a major public health concern in India, affecting women, children and pregnant mothers, leading to severe ...

A pair of privately-held developers of editing-based therapies have some successes to show for their recent efforts to ...

Carlyle Group's acquisition of bluebird bio for $3 per share offers a potential but unlikely $600 million sales milestone by ...

From STAT’s Andrew Joseph: AstraZeneca said this morning it was buying the Belgian cell therapy company EsoBiotec for $425 million upfront, building out another cancer-targeting approach.

The Rutgers Cancer Institute recently became a designated gene therapy treatment center for sickle cell anemia and beta-thalassemia, joining a small group of medical centers that currently provide ...

A recent Duke Health study found patients slightly prefer messages written by artificial intelligence but are less satisfied with the message once they are told it was AI written. The study ...